Skip to content

Author

T. Mamedov

We have 1 of 42 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jun 2026

A rationally designed Wuhan-sequence-based COVID-19 vaccine that maintained effectiveness against diverse SARS-CoV-2 variants, including Omicron: What was the key to success?

The scientific basis of a plant-produced recombinant COVID-19 cocktail vaccine that demonstrated sustained immunogenicity and cross-variant effectiveness despite being designed from the ancestral Wuhan SARS-CoV-2 sequence is discussed.

T. Mamedov · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.